• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮咯酸、羟考酮、曲马多和氨酚羟考酮:全面综述。

Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review.

作者信息

Vadivelu Nalini, Chang Daniel, Helander Erik M, Bordelon Gregory J, Kai Alice, Kaye Alan D, Hsu Dora, Bang Daniel, Julka Inderjeet

机构信息

Department of Anesthesiology, Yale University School of Medicine, 333 Cedar Street, PO Box 208051, New Haven, CT 06520-8051, USA.

Department of Anesthesiology, Yale University School of Medicine, 333 Cedar Street, PO Box 208051, New Haven, CT 06520-8051, USA.

出版信息

Anesthesiol Clin. 2017 Jun;35(2):e1-e20. doi: 10.1016/j.anclin.2017.01.001. Epub 2017 Apr 14.

DOI:10.1016/j.anclin.2017.01.001
PMID:28526155
Abstract

Pain remains a tremendous burden on patients and for the health care system, with uncontrolled pain being the leading cause of disability in this country. There are a variety of medications that can be used in the treatment of pain, including ketorolac, oxymorphone, tapentadol, and tramadol. Depending on the clinical situation, these drugs can be used as monotherapy or in conjunction with other types of medications in a multimodal approach. A strong appreciation of pharmacologic properties of these agents and potential side effects is warranted for clinicians.

摘要

疼痛仍然是患者和医疗保健系统的巨大负担,在这个国家,疼痛控制不佳是导致残疾的主要原因。有多种药物可用于治疗疼痛,包括酮咯酸、羟吗啡酮、曲马多和曲马多。根据临床情况,这些药物可以作为单一疗法使用,也可以与其他类型的药物联合使用,采用多模式方法。临床医生必须充分了解这些药物的药理特性和潜在副作用。

相似文献

1
Ketorolac, Oxymorphone, Tapentadol, and Tramadol: A Comprehensive Review.酮咯酸、羟考酮、曲马多和氨酚羟考酮:全面综述。
Anesthesiol Clin. 2017 Jun;35(2):e1-e20. doi: 10.1016/j.anclin.2017.01.001. Epub 2017 Apr 14.
2
Ketorolac vs tramadol in the treatment of postoperative pain during maxillofacial surgery.酮咯酸与曲马多治疗颌面外科术后疼痛的比较
Minerva Anestesiol. 2001 Sep;67(9):641-6.
3
Patient-controlled analgesia with tramadol versus tramadol plus ketorolac.曲马多自控镇痛与曲马多加酮咯酸的比较。
Minerva Anestesiol. 2006 Jan-Feb;72(1-2):59-67.
4
Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: a double-blind, randomised, controlled trial.舌下酮咯酸与舌下曲马多用于儿童中重度创伤后骨痛的双盲、随机、对照试验。
Arch Dis Child. 2013 Sep;98(9):721-4. doi: 10.1136/archdischild-2012-303527. Epub 2013 May 23.
5
Control of acute pain after major abdominal surgery in 585 patients given tramadol and ketorolac by intravenous infusion.585例接受静脉输注曲马多和酮咯酸的患者腹部大手术后急性疼痛的控制情况。
Drugs Exp Clin Res. 2002;28(2-3):113-8.
6
A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs.酮咯酸与氟尼辛、布托啡诺和羟吗啡酮在控制犬术后疼痛方面的比较。
Can Vet J. 1996 Sep;37(9):557-67.
7
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].[慢性非癌性疼痛的长期阿片类药物治疗。对研究持续时间至少为26周的开放标签延长期试验中的疗效、耐受性和安全性进行系统评价和荟萃分析]
Schmerz. 2015 Feb;29(1):96-108. doi: 10.1007/s00482-014-1452-0.
8
Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: A parallel, double-blind, randomized, placebo-controlled clinical trial.第三磨牙手术后口服酮咯酸与肌内注射曲马多镇痛效果的比较:一项平行、双盲、随机、安慰剂对照临床试验。
Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e637-43. doi: 10.4317/medoral.21077.
9
Preoperative intravenous tramadol versus ketorolac for preventing postoperative pain after third molar surgery.术前静脉注射曲马多与酮咯酸用于预防第三磨牙手术后的疼痛
Int J Oral Maxillofac Surg. 2004 Apr;33(3):274-8. doi: 10.1006/ijom.2003.0515.
10
Is tapentadol an advance on tramadol?曲马多相比,他喷他多是否更具优势?
Consult Pharm. 2009 Nov;24(11):833-40. doi: 10.4140/tcp.n.2009.833.

引用本文的文献

1
A Systematic Review and Meta-analysis of Opioids vs Nonopioids in Acute Pancreatitis.急性胰腺炎中阿片类药物与非阿片类药物的系统评价和荟萃分析
Gastro Hep Adv. 2022 Feb 3;1(1):83-92. doi: 10.1016/j.gastha.2021.09.006. eCollection 2022.
2
Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery.术中使用酮咯酸与卵巢癌手术后的结局
J Clin Med. 2024 Mar 7;13(6):1546. doi: 10.3390/jcm13061546.
3
Does Scheduled Low-Dose Short-Term NSAID (Ketorolac) Modulate Cytokine Levels After Orthopaedic Polytrauma? A Secondary Analysis of a Randomized Clinical Trial.
骨科多发伤后计划小剂量短期 NSAID(酮咯酸)是否调节细胞因子水平?一项随机临床试验的二次分析。
J Orthop Trauma. 2024 Jul 1;38(7):358-365. doi: 10.1097/BOT.0000000000002807.
4
Tramadol and Tapentadol Induce Conditioned Place Preference with a Differential Impact on Rewarding Memory and Incubation of Craving.曲马多和他喷他多诱导条件性位置偏爱,对奖赏记忆和渴求潜伏期有不同影响。
Pharmaceuticals (Basel). 2023 Jan 7;16(1):86. doi: 10.3390/ph16010086.
5
Effects of Ketorolac, Xylazine, and Bupivacaine Multimodal Analgesia on Goats.酮咯酸、二甲噻嗪和布比卡因联合多模式镇痛对山羊的影响。
Arch Razi Inst. 2022 Apr 30;77(2):661-668. doi: 10.22092/ARI.2021.356859.1930. eCollection 2022 Apr.
6
Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats.曲马多和他喷他多的临床药理学及其在犬猫急慢性疼痛不同模型中的治疗效果。
J Adv Vet Anim Res. 2021 Sep 19;8(3):404-422. doi: 10.5455/javar.2021.h529. eCollection 2021 Sep.
7
Perioperative Pain Management and Opioid Stewardship: A Practical Guide.围手术期疼痛管理与阿片类药物管理:实用指南。
Healthcare (Basel). 2021 Mar 16;9(3):333. doi: 10.3390/healthcare9030333.
8
Repeated Administration of Clinically Relevant Doses of the Prescription Opioids Tramadol and Tapentadol Causes Lung, Cardiac, and Brain Toxicity in Wistar Rats.对Wistar大鼠重复给予临床相关剂量的处方阿片类药物曲马多和氨酚羟考酮会导致肺、心脏和脑毒性。
Pharmaceuticals (Basel). 2021 Jan 27;14(2):97. doi: 10.3390/ph14020097.
9
Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain.新奥施康定控释片联合阿片受体拮抗剂治疗慢性疼痛患者的药代动力学和生物等效性评价。
Clin Drug Investig. 2020 Feb;40(2):139-148. doi: 10.1007/s40261-019-00870-w.
10
Evaluation of Abuse and Route of Administration of Extended-Release Tapentadol Among Treatment-Seeking Individuals, as Captured by the Addiction Severity Index-Multimedia Version (ASI-MV).通过成瘾严重程度指数多媒体版(ASI-MV)评估寻求治疗的个体中缓释曲马多的滥用情况及给药途径。
Pain Med. 2020 Sep 1;21(9):1891-1901. doi: 10.1093/pm/pnz250.